Globus Medical Inc - Ordinary Shares - Class A

Globus Medical Inc - Ordinary Shares - Class A

GMED

Get informed when a big investor buys or sells

+ Follow
Market Cap$11.04B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Globus Medical Inc - Ordinary Shares - Class AGlobus Medical Inc - Ordinary Shares - Class A18.9-12%3.5-
$111.67

Target Price by Analysts

43.3% upsideGlobus Medical Target Price DetailsTarget Price
$241.13

Current Fair Value

209.3% upside

Undervalued by 209.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$11.04 Billion
Enterprise Value$10.63 Billion
Dividend Yield$- (-)
Earnings per Share$3.98
Beta1
Outstanding Shares135,364,000

Return

Return on Equity12.40%ROE
Return on Assets10.79%
Return on Invested Capital13.11%

Valuation & Multiples

P/E Ratio18.89P/E Ratio
PEG29.19PEG
Price to Sales3.54Price to Sales
Price to Book Ratio2.29Price to Book Ratio
Enterprise Value to Revenue3.43
Enterprise Value to EBIT16.35
Enterprise Value to Net Income18
Total Debt to Enterprise0.01
Debt to Equity0.03Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 14, 2026
EPS Estimate
$0.92
Average shareholder expectation
Revenue Estimate
$740.34 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 6, 2026
EPS Estimate
$1.12
Average shareholder expectation
Revenue Estimate
$783.82 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.4909 5.67%
Total Calls158,900 87.90%
Total Puts78,000 86.32%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %80.96% 1.63%
Total Invested$9.42B 2.94%
Investors Holding612 29.00%

ESG Score

No data

About Globus Medical Inc

CEO: David Demski

Relevant Senate Committees

Finance

This is a highly relevant committee as it controls taxation (impacting corporate profits), trade, and critically, entitlement spending which includes Medicare and Medicaid reimbursement rates – a direct driver for medical device sales and profitability.

Appropriations

This committee directly allocates discretionary federal spending, determining the precise funding levels for federal healthcare programs (Medicare, Medicaid, VA, NIH) that directly or indirectly purchase and utilize Globus Medical's products.

Health, Education, Labor, and Pensions

This committee directly regulates the FDA, which is the primary regulatory body for medical device approvals, manufacturing quality, and post-market surveillance, making its influence critical for Globus Medical.

Judiciary

This committee's oversight of antitrust laws (critical for M&A activities like Globus Medical's acquisition of NuVasive) and intellectual property rights (patents are vital for medical device innovation) makes it highly relevant.

Veterans' Affairs

This committee's funding decisions for the Department of Veterans Affairs directly impact government healthcare contractors and medical device manufacturers, as VA hospitals are significant purchasers of such equipment.